India, Oct. 29 -- Eli Lilly and Company (LLY) shares surged nearly 7% on Thursday after the pharmaceutical company reported strong third-quarter results, with revenue climbing 39%, driven by demand for its Mounjaro and Zepbound drugs, and raised its full-year revenue guidance.
The stock is trading at $1,374.28, up $85.98 or 6.67%, on the NYSE. It opened at $1,332.73 after closing the previous session at $1,288.30. The stock has traded between $812.25 and $1,408.38 over the past 52 weeks.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....